BMJ Best Practice

参考文献

关键文献

Botto LD, Moore CA, Khoury MJ, et al. Neural tube defects. N Engl J Med. 1999;341:1509-1519.

Ozek MM, Cinalli G, Maixner VJ, eds. Spina bifida management and outcome. Milan, Italy: Springer Press; 2008.

Mitchell LE, Adzick NS, Melchionne J, et al. Spina bifida. Lancet. 2004;364:1885-1895.

Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364:993-1004.

Grivell RM, Andersen C, Dodd JM. Prenatal versus postnatal repair procedures for spina bifida for improving infant and maternal outcomes. Cochrane Database Syst Rev. 2014;(10):CD008825.

参考文章

1.  Shurtleff DB, Lemire R, Warkany J. Embryology, etiology, and epidemiology. In: Shurtleff BD, ed. Myelodysplasias and exstrophies: significance, prevention, and treatment. Orlando, FL: Grune & Statton; 1986:39-64.

2.  Botto LD, Moore CA, Khoury MJ, et al. Neural tube defects. N Engl J Med. 1999;341:1509-1519.

3.  Ozek MM, Cinalli G, Maixner VJ, eds. Spina bifida management and outcome. Milan, Italy: Springer Press; 2008.

4.  Cragan JD, Robert HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis - United States, 1985-1994. MMWR CDC Surveill Summ. 1995;44:1-13.

5.  Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet. 2005;135C:88-94.

6.  Centers for Disease Control and Prevention. Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005. MMWR Morb Mortal Wkly Rep. 2009;57:1409-1413.

7.  Shin M, Besser LM, Siffel C, et al; Congenital Anomaly Multistate Prevalence and Survival Collaborative. Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics. 2010;126:274-279.

8.  Olney RS, Mulinare J. Trends in neural tube defect prevalence, folic acid supplementation, and vitamin supplement use. Semin Perinatol. 2002;26:277-285.

9.  Lary JM, Edmonds LD. Prevalence of spina bifida at birth - United States, 1983-1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ. 1996;45:15-26.

10.  Greene WB, Terry RC, Demasi RA, et al. Effect of race and gender on neurological level in myelomeningocele. Dev Med Child Neurol. 1991;33:110-117.

11.  Williams J, Mai CT, Mulinare J, et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep. 2015;64:1-5.

12.  De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357:135-142.

13.  Boulet SL, Yang Q, Mai C, et al. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol. 2008;82:527-532.

14.  De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, et al. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015;(12):CD007950.

15.  Kennedy DA, Stern SJ, Moretti M, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011;35:2-10.

16.  Khoshnood B, Loane M, de Walle H, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015;351:h5949.

17.  Bell KN, Oakley GP Jr. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol. 2009;85:102-107.

18.  Moore LL, Singer MR, Bradlee ML, et al. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology. 2000;6:689-694.

19.  Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diab Med. 2002;19:322-326.

20.  Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics. 2003;111:1152-1158.

21.  Shaw GM, Quach T, Nelson V, et. al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003;78:972-978.

22.  Botto LD, Lisi A, Robert-Gnansia E, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ. 2005;330:571.

23.  Inskip HM, Crozier SR, Godfrey KM. Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study. BMJ. 2009;338:b481.

24.  Mitchell LE, Adzick NS, Melchionne J, et al. Spina bifida. Lancet. 2004;364:1885-1895.

25.  Canfield MA, Ramadhani TA, Shaw GM. Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2009;85:637-646.

26.  Au KS, Tran PX, Tsai CC, et al. Characteristics of a spina bifida population including North American Caucasian and Hispanic individuals. Birth Defects Res A Clin Mol Teratol. 2008;82:692-700.

27.  Hall JG, Solehdin F. Genetics of neural tube defects. Ment Retard Dev Disabil Res Rev. 1998;4:269-281.

28.  Sebold CD, Melvin EC, Siegel D, et al. Recurrence risks for neural tube defects in siblings of patients with lipomyelomeningocele. Genet Med. 2005:64-67.

29.  Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of anti-epileptic drugs in pregnancy. Reprod Toxicol. 2006;22:214-226.

30.  Tieu J, Middleton P, Crowther CA. Preconception care for diabetic women for improving maternal and infant health. Cochrane Database Syst Rev. 2010;(12):CD007776.

31.  Wasserman CR, Shaw GM, Selvin S, et al. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health. 1998;88:1674-1680.

32.  Suarez L, Felker M, Hendricks K. The effect of fever, febrile illnesses, and heat exposure on the risk of neural tube defects in a Texas-Mexico population. Birth Defects Res A Clin Mol Teratol. 2004;70:815-819.

33.  Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944-950.

34.  Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect occurrence. Lancet. 1983;1:1027-1031.

35.  Mulinare J, Cordero JF, Erickson JD, et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260:3141-3145.

36.  Suarez L, Hendricks K, Felkner M, et al. Maternal serum vitamin B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol. 2003;13:81-88.

37.  Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet. 2005;135C:9-23.

38.  Davidson CM, Northrup H, King TM, et al. Genes in glucose metabolism and association with spina bifida. Reprod Sci. 2008;15:51-58.

39.  Williams H. A unifying hypothesis for hydrocephalus, Chiari malformation, syringomyelia, anencephaly and spina bifida. Cerebrospinal Fluid Res. 2008;5:7.

40.  de Wit OA, den Dunnen WF, Sollie KM, et al. Pathogenesis of cerebral malformations in human fetuses with meningomyelocele. Cerebrospinal Fluid Res. 2008;5:4.

41.  Hasan KM, Eluvathingal TJ, Kramer LA, et al. White matter microstructural abnormalities in children with spina bifida myelomeningocele and hydrocephalus: a diffusion tensor tractography study of the association pathways. J Magn Reson Imaging. 2008;27:700-709.

42.  Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet. 2009;18:R113-R129.

43.  Ross ME. Gene-environment interactions, folate metabolism and the embryonic nervous system. Wiley Interdiscip Rev Syst Biol Med. 2010;4;471-480.

44.  US Preventive Services Task Force. Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150:626-631.

45.  MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.

46.  Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41(RR-14):1-7.

47.  Chen CP. Syndromes, disorders and maternal risk factors associated with neural tube defects (I). Taiwan J Obstet Gynecol. 2008;47:1-9.

48.  Melvin EC, George TM, Worley G, et al. Genetic studies in neural tube defects. NTD Collaborative Group. Pediatr Neurosurg. 2000;32:1-9.

49.  Hall JG, Friedman JM, Kenna BA, et al. Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet. 1988;43:827-837.

50.  Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360:1597-1605.

51.  Lloyd ME, Carr M, McElhatton P. The effects of methotrexate on pregnancy, fertility and lactation. QJM. 1999;92:551-563.

52.  Stothard KJ, Tennant PW, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301:636-650.

53.  Chen CP. Maternal diabetes and neural tube defects: prenatal diagnosis of lumbosacral myelomeningocele, ventriculomegaly, Arnold-Chiari malformation, and foot deformities in a pregnancy with poor maternal metabolic control, and review of the literature. Genet Couns. 2005;16:313-316.

54.  Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based care-control study. Pediatrics. 1990;85:1-9.

55.  Temple R. Preconception care for women with diabetes: is it effective and who should provide it? Best Pract Res Clin Obstet Gynaecol. 2011;25:3-14.

56.  Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004;53:362-365.

57.  Blencowe H, Cousens S, Modell B, et al. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol. 2010;39(suppl 1):i110-i121.

58.  Weggemans RM, Schaafsma G, Kromhout D, et al. Toward an optimal use of folic acid: an advisory report of the Health Council of the Netherlands. Eur J Clin Nutr. 2009;63:1034-1036.

59.  Mills JL, Signore CC. Folic acid and the prevention of neural tube defects. N Engl J Med. 2004;350:2209-2211.

60.  Mehta TS, Levine D. Imaging of fetal cerebral ventriculomegaly: a guide to management and outcome. Semin Fetal Neonatal Med. 2005;10:421-428.

61.  Blaicher W, Mittermayer C, Messerschmidt A. Fetal skeletal deformities - the diagnostic accuracy of prenatal ultrasonography and fetal magnetic resonance imaging. Ultraschall Med. 2004;25:195-199.

62.  Norem CT, Schoen EJ, Walton DL, et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol. 2005;106:747-752.

63.  Bruner JP, Tulipan N, Dabrowiak ME, et al. Upper level of the spina bifida defect: how good are we? Ultrasound Obstet Gynecol. 2004;24:612-617.

64.  Chen CP. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects. Taiwan J Obstet Gynecol. 2008;47:283-290.

65.  Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009;29:402-411.

66.  American College of Radiology. ACR–ACOG–AIUM–SRU practice parameter for the performance of obstetrical ultrasound. 2014. http://www.acr.org/ (last accessed 11 March 2016).

67.  Reddy UM, Abuhamad AZ, Levine D, et al; Fetal Imaging Workshop Invited Participants. Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. Am J Obstet Gynecol. 2014;210:387-397.

68.  Chao TT, Dashe JS, Adams RC, et al. Fetal spine findings on MRI and associated outcomes in children with open neural tube defects. AJR Am J Roentgenol. 2011;197:W956-W961.

69.  Stevenson KL. Chiari type II malformation: past, present, and future. Neurosurg Focus. 2004;16:E5.

70.  Dias MS. Neurosurgical management of myelomeningocele (spina bifida). Pediatr Rev. 2005;26:50-60.

71.  Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364:993-1004.

72.  Pollack IF, Kinnunen D, Albright AL. The effect of early craniocervical decompression on functional outcome in neonates and young infants with myelodysplasia and symptomatic Chiari II malformations: results from a prospective series. Neurosurgery. 1996;38:703-710.

73.  American College of Radiology; American Institute of Ultrasound in Medicine; Society for Pediatric Radiology; Society of Radiologists in Ultrasound. ACR–AIUM–SPR–SRU practice parameter for the performance of an ultrasound examination of the neonatal spine. 2014. http://www.acr.org/ (last accessed 11 March 2016).

74.  Joseph DB. Current approaches to the urologic care of children with spina bifida. Curr Urol Rep. 2008;9:151-157.

75.  Frimberger D, Cheng E, Kropp BP. The current management of the neurogenic bladder in children with spina bifida. Pediatr Clin North Am. 2012;59:757-767.

76.  Visconti D, Noia G, Triarico S, et al. Sexuality, pre-conception counseling and urological management of pregnancy for young women with spina bifida. Eur J Obstet Gynecol Reprod Biol. 2012;163:129-133.

77.  Trivedi J, Thompson JD, Slakey JB, et al. Clinical and radiographic predictors of scoliosis in patients with myelomeningocele. J Bone Joint Surg Am. 2002;84-A:1389-1394.

78.  Tortori-Donati P, Fondellia MP, Rossia A, et al. Segmental spinal dysgenesis: neuroradiologic findings with clinical and embryologic correlation. AJNR Am J Neuroradiol. 1999;20:445-456.

79.  Ryan KD, Plosky C, Emans JB. Myelodysplasia - the musculoskeletal problem: habilitation from infancy to adulthood. Phys Ther. 1991;71:935-946.

80.  Battibugli S, Gryfakis N, Dias L, et al. Functional gait comparison between children with myelomeningocele: shunt versus no shunt. Dev Med Child Neurol. 2007;49:764-769.

81.  Harstall C; Institute of Health Economics (Canada). First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects. September 2012. http://www.ihe.ca/ (last accessed 11 March 2016).

82.  Tulipan N, Wellons JC 3rd, Thom EA, et al; MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015;16:613-620.

83.  Nikkilä A, Rydhström H, Källén B. Incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis. Eur J Public Health. 2006;16:660-662.

84.  Forrester MB, Merz RD. Prenatal diagnosis and elective termination of neural tube defects in Hawaii, 1986-1997. Fetal Diagn Ther. 2000;15:146-151.

85.  Spinner SS, Miesnik SR, Koh JG, et al. Maternal, fetal, and neonatal care in open fetal surgery for myelomeningocele. J Obstet Gynecol Neonatal Nurs. 2012;41:447-454.

86.  Adzick NS. Fetal surgery for spina bifida: past, present, future. Semin Pediatr Surg. 2013;22:10-17.

87.  Brock JW 3rd, Carr MC, Adzick NS, et al; MOMS Investigators. Bladder function after fetal surgery for myelomeningocele. Pediatrics. 2015;136:e906-e913.

88.  Grivell RM, Andersen C, Dodd JM. Prenatal versus postnatal repair procedures for spina bifida for improving infant and maternal outcomes. Cochrane Database Syst Rev. 2014;(10):CD008825.

89.  Lingman G. Management of pregnancy and labour in cases diagnosed with major fetal malformation. Curr Opin Obstet Gynecol. 2005;17:143-146.

90.  Shaer CM, Chescheir N, Erickson K, et al. Obstetrician-gynecologists' practice and knowledge regarding spina bifida. Am J Perinatol. 2006;23:355-362.

91.  Warf BC, Stagno V, Mugamba J. Encephalocele in Uganda: ethnic distinctions in lesion location, endoscopic management of hydrocephalus, and survival in 110 consecutive children. J Neurosurg Pediatr. 2011;7:88-93.

92.  Vogel TW, Bahuleyan B, Robinson S, et al. The role of endoscopic third ventriculostomy in the treatment of hydrocephalus. J Neurosurg Pediatr. 2013;12:54-61.

93.  Drake JM, Kulkarni AV, Kestle J. Endoscopic third ventriculostomy vs ventriculoperitoneal shunt in pediatric patients, a decision analysis. Childs Nerv Syst. 2009;25:467-472.

94.  Jenkinson MD, Hayhurst C, Al-Jumaily M, et al. The role of ETV in adult patients with hydrocephalus. J Neurosurgery. 2009;110:861-866.

95.  Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery. 1998;43:294-303.

96.  Hankinson T, Tubbs RS, Wellons JC. Duraplasty or not? An evidence-based review of the pediatric Chiari I malformation. Childs Nerv Syst. 2011;27:35-40.

97.  Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol. 2003;169:305-308.

98.  Dik P, Klijn AJ, van Gool JD, et al. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49:908-913.

99.  Madden-Fuentes RJ, McNamara ER, Lloyd JC, et al. Variation in definitions of urinary tract infections in spina bifida patients: a systematic review. Pediatrics. 2013;132:132-139.

100.  Lorente Molto FJ, Martinez GI. Retrospective review of L3 myelomeningocele in three groups: should posterolateral iliopsoas transfer still be indicated to stabilize the hip? J Pediatr Orthop B. 2005;14:177-184.

101.  Dias L. Hip dislocation in spina bifida: when is surgery required and what type of surgery should be performed? Ortop Traumatol Rehabil. 2011;13:101-103.

102.  Liptak GS, Garver K, Dosa NP. Spina bifida grown up. J Dev Behav Pediatr. 2013;34:206-215.

103.  Webb TS. Medical care of adults with spina bifida. J Pediatr Rehabil Med. 2009;2:3-11.

104.  Webb TS. Optimizing health care for adults with spina bifida. Dev Disabil Res Rev. 2010;16:76-81.

105.  Dicianno BE, Gaines A, Collins DM, et al. Mobility, assistive technology use, and social integration among adults with spina bifida. Am J Phys Med Rehabil. 2009;88:533-541.

106.  Dicianno BE, Wilson R. Hospitalizations of adults with spina bifida and congenital spinal cord anomalies. Arch Phys Med Rehabil. 2010;91:529-535.

107.  Simon TD, Lamb S, Murphy NA, et al. Who will care for me next? Transitioning to adulthood with hydrocephalus. Pediatrics. 2009;124:1431-1437.

108.  Verhoef M, Lurvink M, Barf HA, et al. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord. 2005;43:331-340.

109.  Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol. 2000;164:958-961.

110.  Arata M, Grover S, Dunne K, et al. Pregnancy outcome and complications in women with spina bifida. J Reprod Med. 2000;45:743-748.

111.  Garcia AM, Dicianno BE. The frequency of lymphedema in an adult spina bifida population. Am J Phys Med Rehabil. 2011;90:89-96.

112.  Valtonen KM, Goksör LA, Jonsson O, et al. Osteoporosis in adults with meningomyelocele: an unrecognized problem at rehabilitation clinics. Arch Phys Med Rehabil. 2006;87:376-382.

113.  Dosa NP, Eckrich M, Katz DA, et al. Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med. 2007;30(Suppl 1):S5-S9.

114.  Stepanczuk BC, Dicianno BE, Webb TS. Young adults with spina bifida may have higher occurrence of prehypertension and hypertension. Am J Phys Med Rehabil. 2014;93:200-206.

115.  Dagenais LM, Lahay ER, Stueck KA, et al. Effects of electrical stimulation, exercise training and motor skills training on strength of children with meningomyelocele: a systematic review. Phys Occup Ther Pediatr. 2009;29:445-463.

116.  Deshpande AV, Sampang R, Smith GH. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children. ANZ J Surg. 2010;80:250-253.

117.  Wang Y, Liu G, Canfield MA, et al; National Birth Defects Prevention Network. Racial/ethnic differences in survival of United States children with birth defects: a population-based study. J Pediatr. 2015;166:819-826.e2.

118.  Moore CA, Li S, Li Z, et al. Elevated rates of severe neural tube defects in a high prevalence area of Northern China. Am J Med Genet. 1997;73:113-118.

119.  Sutton M, Daly LE, Kirke PN. Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Res A Clin Mol Teratol. 2008;82:701-709.

120.  Barf HA, Post MW, Verhoef M, et al. Restrictions in social participation of young adults with spina bifida. Disabil Rehabil. 2009;31:921-927.

121.  Moore C, Kogan BA, Parekh A. Impact of urinary incontinence on self-concept in children with spina bifida. J Urol. 2004;171:1659-1662.

122.  Liptak GS, Kennedy JA, Dosa NP. Youth with spina bifida and transitions: health and social participation in a nationally represented sample. J Pediatr. 2010;157:584-588.

123.  Bowman RM, McLone DG, Grant JA, et al. Spina bifida outcome: a 25-year perspective. Pediatr Neurosurg. 2001;34:114-120.

124.  Davis BE, Daley CM, Shurtleff DB, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg. 2005;41:186-191.

125.  Shin M, Besser LM, Correa A. Prevalence of spina bifida among children and adolescents in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol. 2008;82:748-754.

126.  Ouyang L, Grosse SD, Armour BS, et al. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol. 2007;79:552-558.

127.  Bamer AM, Connell FA, Dudgeon BJ, et al. Frequency of purchase and associated costs of assistive technology for Washington State Medicaid program enrollees with spina bifida by age. Disabil Health J. 2010;3:155-161.

128.  Clayton DB, Brock JW 3rd. The urologist's role in the management of spina bifida: a continuum of care. Urology. 2010;76:32-38.

129.  Piatt JH Jr. Treatment of myelomeningocele: a review of outcomes and continuing neurosurgical considerations among adults. J Neurosurg Pediatr. 2010;6:515-525.

130.  Meeropol E. Latex allergy update: clinical practice and unresolved issues. J Wound Ostomy Continence Nurs. 1996;23:193-196.

131.  Nieto A, Mazon A, Pamies R, et al. Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida. J Pediatrics. 2002;140:370-372.

132.  Cremer R, Kleine-Diepenbruck U, Hering F, et al. Reduction of latex sensitization in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg. 2002;12(suppl 1):S19-S21.

133.  Mazon A, Nieto A, Linana JJ, et al. Latex sensitization in children with spina bifida: follow up comparative study after two years. Ann Allergy Asthma Immunol. 2000;84:207-210.

134.  Casteels K, Fieuws S, van Helvoirt M, et al. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes. 2010;11:61-69.

135.  Hertzler DA 2nd, DePowell JJ, Stevenson CB, et al. Tethered cord syndrome: a review of the literature from embryology to adult presentation. Neurosurg Focus. 2010;29:E1.

136.  Filippidis AS, Kalani MY, Theodore N, et al. Spinal cord traction, vascular compromise, hypoxia, and metabolic derangements in the pathophysiology of tethered cord syndrome. Neurosurg Focus. 2010;29:E9.

137.  Shih P, Halpin RJ, Ganju A, et al. Management of recurrent adult tethered cord syndrome. Neurosurg Focus. 2010;29:E5.

138.  Dicianno BE, Kurowski BG, Yang JM, et al. Rehabilitation and medical management of the adult with spina bifida. Am J Phys Med Rehabil. 2008;87:1027-1050.

139.  Clayton DB, Brock JW 3rd, Joseph DB. Urologic management of spina bifida. Dev Disabil Res Rev. 2010;16:88-95.

140.  Ok JH, Kurzrock EA. Objective measurement of quality of life changes after ACE Malone using the FICQOL survey. J Pediatr Urol. 2011;7:389-393.

141.  Aurora RN, Zak RS, Karippot A, et al. Practice parameters for the respiratory indications for polysomnography in children. Sleep. 2011;34:379-388.

142.  Edelstein K, Cirino PT, Hasher L, et al. Sleep problems, chronotype, and diurnal preferences in children and adults with spina bifida. J Biol Rhythms. 2012;27:172-175.

143.  Thomson JD, Segal LS. Orthopedic management of spina bifida. Dev Disabil Res Rev. 2010;16:96-103.

使用此内容应接受我们的免责声明。